论文部分内容阅读
目的:探讨初善仪(TruScreen)联合阴道镜对宫颈病变的诊断价值。方法:对2009~2011年在黄石市妇幼保健院宫颈病变专科就诊并自愿参加本研究的3 045例妇女分为TruScreen检测组和TCT检测组,阳性者均行阴道镜检查,以病理学诊断为依据,比较两组对宫颈病变的检出率、与病理学诊断的符合率以及诊疗过程中的失访率。结果:TruScreen组的检出率为2.67%,高于TCT组的2.02%,但差异无统计学意义(P>0.05);TruScreen组的符合率为87.18%,低于TCT组的92.86%,差异亦无统计学意义(P>0.05);但TruScreen组的失访率为0,明显低于TCT组的12.50%,差异有统计学意义(P<0.05)。结论:TruScreen联合阴道镜是防治宫颈病变的有效手段,其效果评价不亚于TCT,可做到即筛即治,既能减少患者就诊次数,又可减少患者流失,值得临床推广应用。
Objective: To investigate the diagnostic value of TruScreen combined with colposcopy in cervical lesions. Methods: A total of 3 045 women who visited the hospital for cervical lesions in MCH from 2009 to 2011 and who volunteered for the study were divided into TruScreen test group and TCT test group. The positive patients were examined by colposcopy and pathologically diagnosed as Based on the comparison of the detection rate of cervical lesions, the coincidence rate with the pathological diagnosis and the rate of loss of follow-up during the diagnosis and treatment. Results: The detection rate of TruScreen group was 2.67%, higher than that of TCT group (2.02%), but the difference was not statistically significant (P> 0.05). The coincidence rate of TruScreen group was 87.18%, which was lower than that of TCT group (92.86% (P> 0.05). However, the rate of follow-up in TruScreen group was 0, which was significantly lower than that in TCT group (12.50%, P <0.05). Conclusion: TruScreen colposcopy is an effective method to prevent cervical lesions. The evaluation of its effect is as good as that of TCT. It can reduce the number of visits and reduce the loss of patients, which is worthy of clinical application.